≡

Recombinant Ephrin A4 (EFNA4)

EFL4; EPLG4; LERK4; EPH-related receptor tyrosine kinase ligand 4

  • Product No.RPE110Ra02
  • Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationMembrane
  • Predicted Molecular Mass52.7kDa
  • Accurate Molecular Mass55kDa(Analysis of differences refer to the manual)
  • Residues & TagsMet1~Leu204 with N-terminal His and GST Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder
  • Purity> 90%
  • Isoelectric Point6.5
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 170  US$ 426  US$ 852  US$ 2556  US$ 6390 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPE110Ra01 Recombinant Ephrin A4 (EFNA4) Positive Control; Immunogen; SDS-PAGE; WB.
RPE110Ra02 Recombinant Ephrin A4 (EFNA4) Positive Control; Immunogen; SDS-PAGE; WB.
APE110Ra02 Active Ephrin A4 (EFNA4) Cell culture; Activity Assays.
PAE110Ra01 Polyclonal Antibody to Ephrin A4 (EFNA4) WB; IHC; ICC; IP.
PAE110Ra02 Polyclonal Antibody to Ephrin A4 (EFNA4) WB; IHC; ICC; IP.